Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis

被引:7
作者
Naseri, Mohadeseh [1 ]
Houri, Hamidreza [2 ]
Yadegar, Abbas [2 ]
Aghdaei, Hamid Asadzadeh [3 ]
Zahiri, Javad [4 ]
机构
[1] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Bioinformat & Computat Omics Lab Biocool, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Foodborne & Waterborne Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Basic & Mol Epidemiol Gastrointestinal Disorders, Res Inst Gastroenterol & Liver Dis, Tehran, Iran
[4] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA
关键词
Liver cirrhosis; gut microbiota; non-alcoholic fatty liver disease; alcoholic liver disease; hepatitis; metagenomics; DYSBIOSIS; ALCOHOL;
D O I
10.1080/17474124.2021.1991312
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Liver cirrhosis can develop as a consequence of many chronic liver diseases, such as viral hepatitis, fatty liver, or alcohol abuse. There are insufficient data on whether the different etiologies of liver cirrhosis could be related to the specific gut microbial alterations. This study aimed to compare the diversity and composition of the gut microbiota in different etiologies of liver cirrhosis. Methods In the current study, the authors used three previously reported metagenomic datasets to investigate the fecal microbiota in cirrhotic patients with distinct etiologies. Microbial diversity and bacterial taxonomic composition were investigated bioinformatically in cirrhotic patients with different etiologies. Results The analysis revealed no evidence of a significant difference in microbial diversity between cirrhotic patients with different etiologies. At the family level, cirrhotic patients with nonalcoholic fatty liver disease (NAFLD) showed a significantly higher abundance of the Enterobacteriaceae family and the related genera. Conclusion No robust microbial signal was found to differentiate between various underlying etiologies in cirrhotic patients. The data indicate that the geographical origin of cirrhotic patients could affect the composition of the gut microbiome, the effect of which obscures the impact of the etiology of cirrhosis.
引用
收藏
页码:1435 / 1441
页数:7
相关论文
共 24 条
  • [1] Altered Microbiome in Patients With Cirrhosis and Complications
    Acharya, Chathur
    Bajaj, Jasmohan S.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (02) : 307 - 321
  • [2] Gut Microbiota and Complications of Liver Disease
    Acharya, Chathur
    Bajaj, Jasmohan S.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (01) : 155 - +
  • [3] Targeting Dysbiosis for the Treatment of Liver Disease
    Anand, Gobind
    Zarrinpar, Amir
    Loomba, Rohit
    [J]. SEMINARS IN LIVER DISEASE, 2016, 36 (01) : 37 - 47
  • [4] Decompensated cirrhosis and microbiome interpretation
    Bajaj, Jasmohan S.
    Betrapally, Naga S.
    Gillevet, Patrick M.
    [J]. NATURE, 2015, 525 (7569) : E1 - E2
  • [5] Gorham James, 2016, Hepatology, V63, P336, DOI 10.1002/hep.28133
  • [6] Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma
    Ho, Shu-Yein
    Liu, Po-Hong
    Hsu, Chia-Yang
    Hsia, Cheng-Yuan
    Huang, Yi-Hsiang
    Lei, Hao-Jan
    Su, Chien-Wei
    Lee, Rheun-Chuan
    Hou, Ming-Chih
    Huo, Teh-Ia
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [7] Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
    Jiang, Weiwei
    Wu, Na
    Wang, Xuemei
    Chi, Yujing
    Zhang, Yuanyuan
    Qiu, Xinyun
    Hu, Ying
    Li, Jing
    Liu, Yulan
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [8] Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
  • [9] Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
    Lapidot, Yelena
    Amir, Amnon
    Nosenko, Rita
    Uzan-Yulzari, Atara
    Veitsman, Ella
    Cohen-Ezra, Oranit
    Davidov, Yana
    Weiss, Peretz
    Bradichevski, Tanya
    Segev, Shlomo
    Koren, Omry
    Safran, Michal
    Ben-Ari, Ziv
    [J]. MSYSTEMS, 2020, 5 (03)
  • [10] Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
    Loomba, Rohit
    Seguritan, Victor
    Li, Weizhong
    Long, Tao
    Klitgord, Niels
    Bhatt, Archana
    Dulai, Parambir Singh
    Caussy, Cyrielle
    Bettencourt, Richele
    Highlander, Sarah K.
    Jones, Marcus B.
    Sirlin, Claude B.
    Schnabl, Bernd
    Brinkac, Lauren
    Schork, Nicholas
    Chen, Chi-Hua
    Brenner, David A.
    Biggs, William
    Yooseph, Shibu
    Venter, J. Craig
    Nelson, Karen E.
    [J]. CELL METABOLISM, 2017, 25 (05) : 1054 - +